$PCOR
PROCORE TECHNOLOGIES, INC.

2022 Q3 Form 10-Q Financial Statement

#000156459022028233 Filed on August 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $186.4M $172.2M $159.5M
YoY Change 41.24% 40.24% 40.0%
Cost Of Revenue $37.78M $36.74M $33.33M
YoY Change 66.48% 44.1% 63.72%
Gross Profit $148.7M $135.5M $126.2M
YoY Change 36.01% 39.23% 34.84%
Gross Profit Margin 79.74% 78.67% 79.1%
Selling, General & Admin $149.0M $144.0M $137.1M
YoY Change 41.87% -8.74% 90.66%
% of Gross Profit 100.22% 106.26% 108.62%
Research & Development $71.49M $63.82M $60.25M
YoY Change 36.07% -27.99% 74.42%
% of Gross Profit 48.09% 47.11% 47.75%
Depreciation & Amortization $15.90M $15.40M $15.15M
YoY Change 95.15% 96.97% 107.46%
% of Gross Profit 10.7% 11.37% 12.0%
Operating Expenses $220.5M $207.8M $197.3M
YoY Change 38.78% -15.66% 85.39%
Operating Profit -$71.81M -$72.30M -$71.14M
YoY Change 44.91% -51.5% 453.25%
Interest Expense $504.0K $111.0K $491.0K
YoY Change -196.74% -80.73% -12.63%
% of Operating Profit
Other Income/Expense, Net -$698.0K -$890.0K $543.0K
YoY Change 6.89% 1922.73% -396.72%
Pretax Income -$70.87M -$73.08M -$71.09M
YoY Change 39.7% -51.18% 422.57%
Income Tax $300.0K $42.00K $300.0K
% Of Pretax Income
Net Earnings -$71.21M -$73.12M -$71.42M
YoY Change 40.33% -51.16% 420.09%
Net Earnings / Revenue -38.19% -42.46% -44.77%
Basic Earnings Per Share -$0.52 -$0.54 -$0.53
Diluted Earnings Per Share -$0.52 -$0.54 -$530.9K
COMMON SHARES
Basic Shares Outstanding 136.8M 135.9M 134.5M shares
Diluted Shares Outstanding 137.2M 135.9M 134.5M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $558.1M $563.2M $586.9M
YoY Change -47.95% -46.89% 41.84%
Cash & Equivalents $264.6M $563.2M $586.9M
Short-Term Investments $293.4M
Other Short-Term Assets $49.91M $44.08M $40.73M
YoY Change 109.0% 89.66% 89.44%
Inventory
Prepaid Expenses
Receivables $106.7M $89.27M $98.14M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $735.4M $715.8M $725.8M
YoY Change -38.02% -38.6% 43.29%
LONG-TERM ASSETS
Property, Plant & Equipment $40.67M $41.04M $126.2M
YoY Change -65.42% -65.32% 5.64%
Goodwill $539.0M $539.6M $540.0M
YoY Change 292.36% 292.91%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.09M $23.57M $24.09M
YoY Change 82.1% 198.99% 74.54%
Total Long-Term Assets $941.9M $946.1M $946.5M
YoY Change 165.62% 168.57% 187.86%
TOTAL ASSETS
Total Short-Term Assets $735.4M $715.8M $725.8M
Total Long-Term Assets $941.9M $946.1M $946.5M
Total Assets $1.677B $1.662B $1.672B
YoY Change 8.84% 9.47% 100.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.28M $21.25M $14.41M
YoY Change 82.62% 226.29% 161.96%
Accrued Expenses $83.08M $52.09M $58.89M
YoY Change 48.19% 21.23% 80.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $458.9M $419.4M $408.6M
YoY Change 44.54% 45.82% 50.39%
LONG-TERM LIABILITIES
Long-Term Debt $45.79M $46.45M $46.95M
YoY Change -4.01% -3.23% -3.19%
Other Long-Term Liabilities $3.352M $3.445M $52.31M
YoY Change -93.82% -55.19% 0.4%
Total Long-Term Liabilities $3.352M $3.445M $99.26M
YoY Change -96.71% -55.19% -1.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $458.9M $419.4M $408.6M
Total Long-Term Liabilities $3.352M $3.445M $99.26M
Total Liabilities $553.0M $516.0M $507.9M
YoY Change 31.83% 31.8% 36.45%
SHAREHOLDERS EQUITY
Retained Earnings -$878.0M -$806.8M
YoY Change 43.94%
Common Stock $14.00K $14.00K
YoY Change 7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.124B $1.146B $1.164B
YoY Change
Total Liabilities & Shareholders Equity $1.677B $1.662B $1.672B
YoY Change 8.84% 9.47% 100.2%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$71.21M -$73.12M -$71.42M
YoY Change 40.33% -51.16% 420.09%
Depreciation, Depletion And Amortization $15.90M $15.40M $15.15M
YoY Change 95.15% 96.97% 107.46%
Cash From Operating Activities $6.587M -$26.96M $10.28M
YoY Change -56.49% 760.36% -63.66%
INVESTING ACTIVITIES
Capital Expenditures -$12.77M -$10.53M $7.525M
YoY Change 47.27% 97.89% 214.46%
Acquisitions
YoY Change
Other Investing Activities -$295.5M -$3.687M -$1.038M
YoY Change 3693250.0% -84.27%
Cash From Investing Activities -$308.2M -$14.22M -$16.20M
YoY Change 3451.92% -50.56% 253.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.255M 18.46M 6.542M
YoY Change -21.71% -97.28% -39.27%
NET CHANGE
Cash From Operating Activities 6.587M -26.96M 10.28M
Cash From Investing Activities -308.2M -14.22M -16.20M
Cash From Financing Activities 4.255M 18.46M 6.542M
Net Change In Cash -297.4M -22.71M 631.0K
YoY Change -2600.16% -103.51% -98.17%
FREE CASH FLOW
Cash From Operating Activities $6.587M -$26.96M $10.28M
Capital Expenditures -$12.77M -$10.53M $7.525M
Free Cash Flow $19.36M -$16.43M $2.759M
YoY Change -18.7% -851.12% -89.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23569000
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Assets
Assets
1661954000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21251000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52087000
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
316559000
us-gaap Net Income Loss
NetIncomeLoss
-163451000
CY2022Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
19251000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
715831000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89274000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41035000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44082000
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
42335000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
182501000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
38291000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48410000
CY2022Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
30398000
CY2022Q2 us-gaap Goodwill
Goodwill
539584000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3943000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
46451000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42762000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3445000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136799885
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136799885
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
14000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1953764000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-806754000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1145995000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1661954000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172205000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-149719000
us-gaap Net Income Loss
NetIncomeLoss
-144542000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-791000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73914000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6795000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1145995000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1126662000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
103283000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
111000
CY2022Q2 us-gaap Liabilities
Liabilities
515959000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1029000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
36735000
CY2022Q2 us-gaap Gross Profit
GrossProfit
135470000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.11
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135927677
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73539568
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135232404
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52564840
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29461000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
419358000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63822000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40667000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
207772000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-72302000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-576000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-380000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1138000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-890000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-347000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-227000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73081000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-149682000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-144166000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-163285000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
37000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
376000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-73123000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-149719000
us-gaap Net Income Loss
NetIncomeLoss
-144542000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.04
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135927677
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73539568
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135232404
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52564840
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-73123000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-149919000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-144988000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-163675000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-272102000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11038000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9710000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-13732000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-265110000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17658000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
138055000
CY2021Q2 pcor Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponInitialPublicOffering
728375000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
657618000
CY2021Q2 pcor Issuance Of Common Stock Net Of Common Stock Withheld For Tax Liability Upon Settlement Of Restricted Stock Units
IssuanceOfCommonStockNetOfCommonStockWithheldForTaxLiabilityUponSettlementOfRestrictedStockUnits
-15000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-200000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-149719000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1189289000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39375000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
345000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-71419000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1164385000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8220000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35790000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
11513000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-791000
us-gaap Profit Loss
ProfitLoss
-144542000
us-gaap Profit Loss
ProfitLoss
-163451000
us-gaap Share Based Compensation
ShareBasedCompensation
71104000
us-gaap Share Based Compensation
ShareBasedCompensation
147746000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30550000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15120000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-887000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-554000
pcor Noncash Lease Expense
NoncashLeaseExpense
-4808000
pcor Noncash Lease Expense
NoncashLeaseExpense
-3735000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24337000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11113000
pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
7361000
pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
5062000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4535000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5723000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5926000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2908000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8909000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
14535000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
15706000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10845000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4359000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1929000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16671000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25167000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9433000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4194000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
16252000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
5716000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3018000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3450000
pcor Proceeds To Acquire Originations Of Materials Financing
ProceedsToAcquireOriginationsOfMaterialsFinancing
9259000
pcor Proceeds To Acquire Customer Repayments Of Materials Financing
ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing
6261000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19982000
pcor Settlement Of Post Close Working Capital Adjustments From Business Combinations
SettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinations
1291000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30410000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33342000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
665129000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14604000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29126000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
270000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3527000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
11513000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
475000
pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
844000
pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
742000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25003000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
689511000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22078000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
681336000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-806000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-731000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
589212000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
383253000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
566328000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1063858000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
563224000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1060512000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
242000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3104000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3104000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
566328000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1063858000
us-gaap Interest Paid Net
InterestPaidNet
74000
us-gaap Interest Paid Net
InterestPaidNet
110000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
832000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
214000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
568000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1070000
pcor Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
1017000
pcor Operating Cash Flows From Finance Leases
OperatingCashFlowsFromFinanceLeases
1046000
us-gaap Operating Lease Payments
OperatingLeasePayments
5595000
us-gaap Operating Lease Payments
OperatingLeasePayments
3713000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
935000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
835000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3024000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1158000
pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
1365000
pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
666000
pcor Net Change In Deferred Offering Costs Accrued But Not Paid
NetChangeInDeferredOfferingCostsAccruedButNotPaid
641000
pcor Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockUponInitialPublicOffering
728375000
pcor Indemnity Holdback Consideration Associated With Business Combination
IndemnityHoldbackConsiderationAssociatedWithBusinessCombination
4050000
pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
4061000
pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
920000
pcor Conversion Of Available For Sale Debt Securities Into Equity Securities
ConversionOfAvailableForSaleDebtSecuritiesIntoEquitySecurities
3550000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11237000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
37000
pcor Noncash Net Change Due To Operating Lease Remeasurements
NoncashNetChangeDueToOperatingLeaseRemeasurements
-1671000
pcor Noncash Net Change Due To Operating Lease Remeasurements
NoncashNetChangeDueToOperatingLeaseRemeasurements
9000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.34%;text-indent:0%;;color:#231F20;font-size:10pt;font-weight:bold;font-style:italic;font-family:Arial;text-transform:none;font-variant: normal;">Use<span style="letter-spacing:-0.05pt;"> </span>of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.34%;color:#231F20;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>preparation<span style="letter-spacing:-0.05pt;"> </span>of condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>in<span style="letter-spacing:-0.05pt;"> </span>conformity<span style="letter-spacing:0.05pt;"> </span>with<span style="letter-spacing:-0.05pt;"> </span>U.S. GAAP requires management to make estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>that affect<span style="letter-spacing:0.05pt;"> </span>the reported amounts of assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>disclosure<span style="letter-spacing:-0.05pt;"> </span>of contingent<span style="letter-spacing:-0.05pt;"> </span>assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>at the date of the condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>the reported amounts of revenue<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>expenses during<span style="letter-spacing:-0.05pt;"> </span>the reporting period. Management periodically<span style="letter-spacing:-0.1pt;"> </span>evaluates<span style="letter-spacing:-0.05pt;"> </span>its estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>for continued<span style="letter-spacing:-0.05pt;"> </span>reasonableness,<span style="letter-spacing:-0.05pt;"> </span>primarily with<span style="letter-spacing:-0.05pt;"> </span>respect to revenue<span style="letter-spacing:-0.05pt;"> </span>recognition,<span style="letter-spacing:-0.05pt;"> </span>the period<span style="letter-spacing:-0.05pt;"> </span>of benefit of contract<span style="letter-spacing:0.05pt;"> </span>cost assets, the fair value<span style="letter-spacing:-0.05pt;"> </span>of assets acquired<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>assumed in<span style="letter-spacing:-0.05pt;"> </span>a business combination,<span style="letter-spacing:-0.05pt;"> </span>stock-based compensation<span style="letter-spacing:-0.05pt;"> </span>expense, including<span style="letter-spacing:-0.05pt;"> </span>the fair value<span style="letter-spacing:-0.05pt;"> </span>of the Company’s<span style="letter-spacing:-0.05pt;"> </span>common stock prior to the effective date of the Company’s initial public offering (“IPO”)<span style="letter-spacing:0.05pt;">, </span>the recoverability<span style="letter-spacing:-0.05pt;"> </span>of goodwill<span style="letter-spacing:-0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, useful<span style="letter-spacing:-0.05pt;"> </span>lives<span style="letter-spacing:-0.05pt;"> </span>of long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, capitalization<span style="letter-spacing:-0.1pt;"> </span>of software development<span style="letter-spacing:-0.05pt;"> </span>costs<span style="letter-spacing:-0.1pt;">,</span><span style="letter-spacing:-0.05pt;"> </span>income<span style="letter-spacing:-0.05pt;"> </span>taxes, including<span style="letter-spacing:-0.1pt;"> </span>related reserves and<span style="letter-spacing:-0.05pt;"> </span>allowances, and self-insurance reserve estimates. Appropriate<span style="letter-spacing:-0.05pt;"> </span>adjustments, if any, to the estimates used<span style="letter-spacing:-0.05pt;"> </span>are made prospectively<span style="letter-spacing:-0.05pt;"> </span>based<span style="letter-spacing:-0.05pt;"> </span>upon<span style="letter-spacing:-0.05pt;"> </span>such periodic<span style="letter-spacing:-0.05pt;"> </span>evaluation.<span style="letter-spacing:-0.05pt;"> </span>Management bases<span style="letter-spacing:-0.05pt;"> </span>its estimates on historical<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>on various<span style="color:#000000;"> </span>other assumptions<span style="letter-spacing:-0.05pt;"> </span>that management believes<span style="letter-spacing:-0.1pt;"> </span>to be reasonable.<span style="letter-spacing:-0.05pt;"> </span>Actual<span style="letter-spacing:-0.05pt;"> </span>results could<span style="letter-spacing:-0.05pt;"> </span>differ from our estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.34%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of the currently unknown duration and severity of the COVID-19 pandemic, we face a greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies. As of the date these condensed consolidated financial statements were issued, the impacts of the COVID-19 pandemic did not have a significant impact on our estimates or judgments. Judgments and assumptions may change, as new events occur and additional information is obtained, as well as other factors related to the COVID-19 pandemic and economic recovery that could result in a meaningful impact on our condensed consolidated financial statements in future reporting periods.</p>
pcor Impairment On Investments
ImpairmentOnInvestments
0
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3500000
pcor Available For Debt Securities Changes In Impairment
AvailableForDebtSecuritiesChangesInImpairment
0
pcor Employee Stock Purchase Plan Number Of End Participation Period Description
EmployeeStockPurchasePlanNumberOfEndParticipationPeriodDescription
Participants may end their participation at any time prior to the last 15 days of a purchase period
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
138280000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
75165000
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
140700000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
103600000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
214300000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
156100000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
653900000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
21.89
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6271982
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.85
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5548427
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
2000000.0
CY2022Q2 us-gaap Receivables From Customers
ReceivablesFromCustomers
12000000.0
CY2021Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
4400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
148666000
CY2022Q2 pcor Operating Lease Right Of Use Assets Operating Lease Liabilities
OperatingLeaseRightOfUseAssetsOperatingLeaseLiabilities
11200000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
223964000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
41463000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
182501000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
224123000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22146000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201977000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.77
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M18D
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9655000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2232000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19317000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3980000
CY2022Q2 us-gaap Goodwill
Goodwill
539600000
pcor Goodwill Decreased By Due To Settlement Of Post Close Working Capital Adjustments From Business Combinations And Effect Of Foreign Currency Translation
GoodwillDecreasedByDueToSettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinationsAndEffectOfForeignCurrencyTranslation
1300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33895000
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6500000
CY2022Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6500000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15120413
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
84477597
CY2022Q2 pcor Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
22630000
CY2021Q4 pcor Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
29676000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13783000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25997000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15674000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10234000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52087000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65907000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
331721000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236728000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
137443000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
71104000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
147746000
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1895000
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
837000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4061000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
920000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
35790000
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
100000000.0
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2022-05-07
pcor Line Of Credit Facility Termination Date
LineOfCreditFacilityTerminationDate
2022-04-29
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7642690
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.98
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1207503
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
163205
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15673629
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66593092
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
172205000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122790000

Files In Submission

Name View Source Status
0001564590-22-028233-index-headers.html Edgar Link pending
0001564590-22-028233-index.html Edgar Link pending
0001564590-22-028233.txt Edgar Link pending
0001564590-22-028233-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g0iplmmx04ni000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pcor-10q_20220630.htm Edgar Link pending
pcor-10q_20220630_htm.xml Edgar Link completed
pcor-20220630.xsd Edgar Link pending
pcor-20220630_cal.xml Edgar Link unprocessable
pcor-20220630_def.xml Edgar Link unprocessable
pcor-20220630_lab.xml Edgar Link unprocessable
pcor-20220630_pre.xml Edgar Link unprocessable
pcor-ex101_63.htm Edgar Link pending
pcor-ex311_8.htm Edgar Link pending
pcor-ex312_6.htm Edgar Link pending
pcor-ex321_9.htm Edgar Link pending
pcor-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending